Literature DB >> 26530541

Patterns of Regional Lymph Node Recurrence After Radical Surgery for Thoracic Esophageal Squamous Cell Carcinoma.

San-Gang Wu1, Ming-Ming Dai1, Zhen-Yu He2, Jia-Yuan Sun2, Huan-Xin Lin2, Hui Lin3, Qun Li4.   

Abstract

BACKGROUND: This study aimed to investigate the patterns of regional lymph node recurrence after radical surgery for thoracic esophageal squamous cell carcinoma (ESCC).
METHODS: We retrospectively reviewed clinical characteristics of ESCC patients admitted to two institutions from 1990 to 2011, and analyzed the patterns of regional lymph node recurrence.
RESULTS: The records of 315 eligible patients with ESCC were reviewed. Of the 378 regional lymph node recurrence sites, 177 (46.8%) were in the supraclavicular areas, 120 (31.7%) in the mediastinum, and 81 (21.4%) in the upper abdominal areas. The most common sites of recurrence were the supraclavicular and mediastinum areas in patients with upper and middle thoracic ESCC. Approximately equal percentages of patients with lower thoracic tumors had supraclavicular, mediastinal, and upper abdominal (celiac) lymph node recurrence. Patients with tumor located in the lower thoracic esophagus had a lower probability of supraclavicular lymph node recurrence (p = 0.013). None of the assessed factors was associated with mediastinal lymph node recurrence. Celiac lymph node recurrence was more frequent among patients with lower thoracic ESCC (p = 0.004) and advanced pathologic nodal (pN) stage (pN2, p = 0.034; pN3, p = 0.009).
CONCLUSIONS: After radical surgery for thoracic ESCC, the patterns of regional lymph node recurrence are related to the tumor location and pN stage.
Copyright © 2016 The Society of Thoracic Surgeons. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2015        PMID: 26530541     DOI: 10.1016/j.athoracsur.2015.08.057

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  8 in total

1.  Mapping patterns of nodal metastases in esophageal carcinoma: rethinking the clinical target volume for supraclavicular nodal irradiation.

Authors:  Yijun Luo; Yuhui Liu; Xiaoli Wang; Bin Zhang; Jinming Yu; Chengang Wang; Yong Huang; Minghuan Li
Journal:  J Thorac Dis       Date:  2016-11       Impact factor: 2.895

Review 2.  Patterns of failure after salvage chemoradiotherapy for postoperative loco-regional recurrent esophageal cancer: 20-year experience in a single institution in Japan.

Authors:  Keiichi Jingu; Rei Umezawa; Takaya Yamamoto; Noriyoshi Takahashi; Kazuya Takeda; Yu Suzuki; Keita Kishida; So Omata; Yuta Sato; Noriyuki Kadoya
Journal:  Esophagus       Date:  2022-05-16       Impact factor: 3.671

3.  A retrospective study of pattern of recurrence after radical surgery for thoracic esophageal carcinoma with or without postoperative radiotherapy.

Authors:  Yichun Wang; Li Zhang; Dongmei Ye; Wanli Xia; Jun Jiang; Xiumei Wang; Mingxia Zhang; Fan Wang
Journal:  Oncol Lett       Date:  2018-01-16       Impact factor: 2.967

4.  Recurrence pattern of squamous cell carcinoma in the midthoracic esophagus: implications for the clinical target volume design of postoperative radiotherapy.

Authors:  Xiaoli Wang; Yijun Luo; Minghuan Li; Hongjiang Yan; Mingping Sun; Tingyong Fan
Journal:  Onco Targets Ther       Date:  2016-10-03       Impact factor: 4.147

5.  Identification of risk factors and the pattern of lower cervical lymph node metastasis in esophageal cancer: implications for radiotherapy target delineation.

Authors:  Yijun Luo; Xiaoli Wang; Yuhui Liu; Chengang Wang; Yong Huang; Jinming Yu; Minghuan Li
Journal:  Oncotarget       Date:  2017-06-27

6.  The impact of adjuvant therapies on patient survival and the recurrence patterns for resected stage IIa-IVa lower thoracic oesophageal squamous cell carcinoma.

Authors:  Yichun Wang; Liyang Zhu; Wanli Xia; Liming Wu; Fan Wang
Journal:  World J Surg Oncol       Date:  2018-11-07       Impact factor: 2.754

7.  Comparison of minimally invasive Ivor Lewis esophagectomy and left transthoracic esophagectomy in esophageal squamous cell carcinoma patients: a propensity score-matched analysis.

Authors:  Qi Wang; Zixiang Wu; Tianwei Zhan; Shuai Fang; Sai Zhang; Gang Shen; Ming Wu
Journal:  BMC Cancer       Date:  2019-05-27       Impact factor: 4.638

8.  Adjuvant radiotherapy, chemotherapy or surgery alone for high-risk histological node negative esophageal squamous cell carcinoma: Protocol for a multicenter prospective randomized controlled trial.

Authors:  Xufeng Guo; Wentao Fang; Zhigang Li; Zhengtao Yu; Tiehua Rong; Jianhua Fu; Yongtao Han; Lijie Tan; Chun Chen; Shuoyan Liu; Yongde Liao; Gaoming Xiao; Yucheng Wei; Chengchu Zhu; Hecheng Li; Jinhua Luo; Wenqun Xing
Journal:  Thorac Cancer       Date:  2018-10-01       Impact factor: 3.500

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.